Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

27 Jan 2015 07:01

RNS Number : 1870D
Kingspan Group PLC
27 January 2015
 

Kingspan Group plc

 

Acquisition

 

 

27 January 2015

 

Kingspan Group plc ("Kingspan") announces the acquisition of Joris Ide Group

 

Kingspan, the global leader in high performance insulation and building envelopes, is pleased to announce that it has entered into an agreement with Ergon Capital Partners II NV and Bremhove NV, to acquire 100% of the shares of Steel Partners NV, the holding company of the Joris Ide Group ("Joris Ide").

 

Joris Ide is a pan European manufacturer and supplier of insulated panels, profiles and related accessories, with leading market positions in France and the Benelux. It has 5 insulated panel manufacturing facilities in Belgium, Germany, Romania and Russia, and 11 regional manufacturing sites across Europe, which provide a uniquely complementary geographic footprint to Kingspan's existing European insulated panel business.

 

The consideration for the business will be circa EUR315m inclusive of debt, which will vary depending on the specific amount of working capital and debt on completion. The consideration will be satisfied on completion partly in cash and by the assumption of debt, with the balance of the consideration satisfied by the issue of three million shares in Kingspan Group plc to Bremhove NV, which is the holding company of the founder and major shareholder Mr Joris Ide.

 

In the 12 months to 31 December 2014, Joris Ide had unaudited revenues of EUR465m and EBITDA of EUR36m. Revenues and adjusted EBITDA to 31 December 2013 were EUR435m and EUR28m respectively. As at 31 December 2013, Joris Ide had gross assets of EUR316m, and on completion net assets excluding goodwill are expected to be EUR135m. The acquisition is expected to enhance earnings by circa 7 cent on a fully annualised basis.

 

The existing management team of Joris Ide will be retained in the business, and will continue to manage and develop the business distinct from the Kingspan brand. The acquisition is conditional on regulatory clearance, and is expected to complete towards the end of the first quarter of 2015.

 

Kingspan also announces that it has negotiated EUR127.5m private placement loan notes with weighted average maturities of 8 years. The weighted average coupon on the new notes is 1.92%. The proceeds will be primarily used to repay private placement loan notes which are due to mature in March 2015. Kingspan has also negotiated additional bilateral facilities of EUR190m. These facilities, together with cash and drawings from the previously undrawn Revolving Credit Facility, will be used to fund the Joris Ide and previously announced Vicwest acquisitions.

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of Joris Ide Group represents a quantum leap forward in the execution of our strategy to fully globalise Kingspan. It takes us into a distinctly different tier in the market than typically occupied by the Kingspan branded products, and with its operations in Belgium, France, Germany, Romania and Russia significantly extends the reach of our Group."

 

Kingspan will hold an analysts' call at 8.30 GMT on 27 January 2015 to discuss the acquisition. A recording of this conference call will be available from 10.00 GMT on 27 January 2015 and full details of the number to call will be available on our website. For further information about the conference call please contact: julie.shankey@kingspan.com or +353 (0)42 969 8016.

 

 

 

For further information contact:

 

 

Kingspan

Gene Murtagh/Geoff Doherty

 

+353 42 9698000

Murray Consultants

Douglas Keatinge

+353 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEANFKASSSEFF
Date   Source Headline
7th Mar 20173:57 pmRNSAnnual Financial Report
6th Mar 20177:00 amRNSMain Securities Market Notice
1st Mar 20175:38 pmRNSDirector/PDMR Shareholding
1st Mar 20179:49 amRNSDirector/PDMR Shareholding
1st Mar 20179:30 amRNSTotal Voting Rights
27th Feb 20174:32 pmRNSDirector/PDMR Shareholding
23rd Feb 201710:20 amRNSBlock Listing Application
22nd Feb 20173:04 pmRNSDirector/PDMR Shareholding
20th Feb 20174:36 pmRNSDirector/PDMR Shareholding
20th Feb 201712:32 pmRNSDirector/PDMR Shareholding
17th Feb 20171:51 pmRNSHolding(s) in Company
17th Feb 20177:00 amRNSFinal Results
24th Jan 201712:04 pmRNSNotice of Results
18th Jan 201711:19 amRNSHolding(s) in Company
3rd Jan 20179:45 amRNSHolding(s) in Company
3rd Jan 20179:30 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSTotal Voting Rights
14th Dec 20165:02 pmRNSHolding(s) in Company
12th Dec 20164:09 pmRNSHolding(s) in Company
1st Dec 20162:28 pmRNSTotal Voting Rights
29th Nov 20162:30 pmRNSHolding(s) in Company
23rd Nov 20165:04 pmRNSHolding(s) in Company
21st Nov 20162:33 pmRNSDirector/PDMR Shareholding
16th Nov 20165:07 pmRNSCompletion of US private placement
16th Nov 20162:44 pmRNSHolding(s) in Company
14th Nov 20167:00 amRNSTrading Update
10th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 201611:08 amRNSHolding(s) in Company
1st Nov 20161:15 pmRNSTotal Voting Rights
21st Oct 201612:46 pmRNSHolding(s) in Company
3rd Oct 20161:27 pmRNSTotal Voting Rights
26th Sep 201610:01 amRNSHolding(s) in Company
1st Sep 20163:39 pmRNSDirector/PDMR Shareholding
1st Sep 201611:00 amRNSTotal Voting Rights
25th Aug 20164:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20167:00 amRNSHalf-year Report
2nd Aug 201610:10 amRNSHolding(s) in Company
27th Jul 20165:39 pmRNSHolding(s) in Company
25th Jul 20165:09 pmRNSHolding(s) in Company
14th Jul 20162:18 pmRNSHolding(s) in Company
1st Jul 20164:43 pmRNSHolding(s) in Company
1st Jul 20169:15 amRNSBlock listing Interim Review
1st Jul 20169:00 amRNSTotal Voting Rights
28th Jun 201610:21 amRNSHolding(s) in Company
10th Jun 20163:15 pmRNSHolding(s) in Company
1st Jun 20169:57 amRNSTotal Voting Rights
24th May 20165:02 pmRNSDirector/PDMR Shareholding
20th May 20164:28 pmRNSDirector/PDMR Shareholding
19th May 20164:25 pmRNSDirector/PDMR Shareholding
12th May 20162:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.